Durable remissions may be achieved with tositumomab and I131 tositumomab in recurrent and refractory B cell lymphoma.

AJ Davies, JA Radford, AZS Rohatiner, K Britton, S Owens, DP Deakin, S Howell, BM Carrington, JA Lawrence, IN Micallef, S Vinnicombe, J Clayton, J Matthews, M Harris, A Norton, TA Lister

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageUndefined
Pages (from-to)667
Number of pages1
Issue number3
Publication statusPublished - Mar 2003
Event5th International Symposium on Leukemia and Lymphoma - Vrije University, Amsterdam, Netherlands
Duration: 12 Mar 200315 Mar 2003

Research Beacons, Institutes and Platforms

  • National Graphene Institute

Cite this